TherapeuticsMD, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
TherapeuticsMD, Inc. (TXMD) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$78.53 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2011-11-07
- TherapeuticsMD, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2011-09-30 was -$78.53K.
- TherapeuticsMD, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2011-06-30 was -$57.07K.
- TherapeuticsMD, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2010-09-30 was -$122.53K.
- TherapeuticsMD, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2010-06-30 was -$75.19K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2011-09-30 | -$78.53K 10-Q · filed 2011-11-07 | -$135.60K derived: sum of 2 quarters · filed 2011-11-07 | -$181.23K 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$57.07K 10-Q · filed 2011-08-15 | -$102.70K 10-Q · filed 2011-08-15 | |
| 2010-09-30 | -$122.53K 10-Q · filed 2011-11-07 | -$197.73K derived: sum of 2 quarters · filed 2011-11-07 | -$327.74K 10-Q · filed 2011-11-07 |
| 2010-06-30 | -$75.19K 10-Q · filed 2011-08-15 | -$205.21K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |